Table. 2 Baseline characteristics of the E-AKI cohort
Baseline characteristics | Non_AKI (n = 46) | Subclinical AKI (n = 26) | p-value |
|---|---|---|---|
Age (year) | 73.000 (68.000–78.500) | 69.000 (59.000–77.500) | 0.263 |
Max_Scr (mg/dl) | 0.735 (0.585–0.899) | 2.368 (1.559–2.866) | 1.0E−15 |
eGFR (mL/min/1.73m2) | 91.112 (78.960–100.349) | 27.061 (20.308–39.360) | 4.0E−15 |
Procalcitonin (ng/ml) | 2.524 (0.570–6.275) | 8.753 (0.960–16.419) | 0.023 |
Hs-CRP (mg/L) | 55.460 (25.290–103.880) | 104.810 (68.525–162.612) | 0.040 |
Urine (ml/24 h) | 1580.000 (1170.000–1885.000) | 1090.000 (972.500–1406.250) | 0.005 |
Hemoglobin (g/L) | 108.000 (93.500–113.500) | 103.000 (82.500–111.250) | 0.275 |
SOFA | 9.000 (7.000–11.000) | 9.000 (7.250–10.000) | 0.63 |
Gender (%) | 0.843 | ||
Male | 29 (63.04%) | 17 (65.38%) | |
Female | 17 (36.96%) | 9 (34.62%) | |
AKI stage (%) | |||
0 | 46 (100.00%) | – | 1.0E-15 |
1 | – | 11 (42.31%) | |
2 | – | 11 (42.31%) | |
3 | – | 4 (15.38%) | |
Hypertension (%) | 0.421 | ||
No | 24 (52.17%) | 11 (42.31%) | |
Yes | 22 (47.83%) | 15 (57.69%) | |
Diabetes (%) | 0.488 | ||
No | 32 (69.57%) | 16 (61.54%) | |
Yes | 14 (30.43%) | 10 (38.46%) | |
Smoking (%) | 0.826 | ||
No | 38 (82.61%) | 22 (84.62%) | |
Yes | 8 (17.39%) | 4 (15.38%) | |
Cardiovascular diseases (%) | 0.411 | ||
No | 31 (67.39%) | 15 (57.69%) | |
Yes | 15 (32.61%) | 11 (42.31%) | |
Source of infection (%) | 0.113 | ||
Bacteria | 18 (39.13%) | 16 (61.54%) | |
Virus | 6 (13.04%) | 4 (15.38%) | |
Fungus | 6 (13.04%) | 0 (0.00%) | |
Undetected | 16 (34.78%) | 6 (23.08%) | |
Mechanical ventilation (%) | 0.53 | ||
No | 23 (50.00%) | 11 (42.31%) | |
Yes | 23 (50.00%) | 15 (57.69%) | |
Catecholamines (%) | 0.038 | ||
No | 24 (52.17%) | 7 (26.92%) | |
Yes | 22 (47.83%) | 19 (73.08%) |
